NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Guard Therapeutics International AB (publ) (ST: GUARD)
GUARD Technical Analysis
2
As on 11th Mar 2025 GUARD STOCK Price closed @ 16.70 and we RECOMMEND Sell for LONG-TERM with Stoploss of 21.22 & Strong Buy for SHORT-TERM with Stoploss of 0.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GUARDSTOCK Price
Open | 16.20 | Change | Price | % |
High | 17.30 | 1 Day | 0.10 | 0.60 |
Low | 15.50 | 1 Week | -3.70 | -18.14 |
Close | 16.70 | 1 Month | -5.30 | -24.09 |
Volume | 5813 | 1 Year | 15.97 | 2187.67 |
52 Week High 39.00 | 52 Week Low 0.50 |
ST Sweden Most Active Stocks
ATORX | 0.01 | 0.00% |
WYLD | 0.04 | 0.00% |
FING-B | 0.01 | 0.00% |
LIPI | 0.26 | -3.70% |
QLINEA | 0.04 | 0.00% |
KEBNI-B | 2.23 | 10.40% |
ENERS | 0.00 | % |
SBB-B | 3.48 | -2.25% |
LUNE | 21.97 | 6.65% |
TELIA | 35.73 | 1.16% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
GUARD Daily Charts |
GUARD Intraday Charts |
Whats New @ Bazaartrend |
GUARD Free Analysis |
|
GUARD Important Levels Intraday
RESISTANCE | 20.17 |
RESISTANCE | 19.06 |
RESISTANCE | 18.37 |
RESISTANCE | 17.68 |
SUPPORT | 15.72 |
SUPPORT | 15.03 |
SUPPORT | 14.34 |
SUPPORT | 13.23 |
GUARD Forecast March 2025
4th UP Forecast | 17.2 |
3rd UP Forecast | 17.04 |
2nd UP Forecast | 16.94 |
1st UP Forecast | 16.84 |
1st DOWN Forecast | 16.56 |
2nd DOWN Forecast | 16.46 |
3rd DOWN Forecast | 16.36 |
4th DOWN Forecast | 16.2 |
GUARD Weekly Forecast
4th UP Forecast | 17.49 |
3rd UP Forecast | 17.24 |
2nd UP Forecast | 17.08 |
1st UP Forecast | 16.92 |
1st DOWN Forecast | 16.48 |
2nd DOWN Forecast | 16.32 |
3rd DOWN Forecast | 16.16 |
4th DOWN Forecast | 15.91 |
GUARD Forecast2025
4th UP Forecast | 104.42 |
3rd UP Forecast | 76.29 |
2nd UP Forecast | 58.9 |
1st UP Forecast | 41.51 |
1st DOWN Forecast | -8.11 |
2nd DOWN Forecast | -25.5 |
3rd DOWN Forecast | -42.89 |
4th DOWN Forecast | -71.02 |
Guard Therapeutics International AB (publ) ( ST Sweden Symbol : GUARD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GUARD Other Details
Segment | EQ | |
Market Capital | 284566656.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
GUARD Address
![]() |
GUARD Latest News
GUARD Business Profile
Guard Therapeutics International AB (publ) develops and commercializes medical applications for the diagnosis and treatment of pre-eclampsia and kidney damage in Sweden. It offers ROSGard, a drug candidate that is based on alpha-1-microglobulin protein, which protects and repairs damaged kidney tissues. The company has collaboration with Antaros Medical to conduct a study in humans undergoing radiation therapy of neuroendocrine tumors. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) is based in Lund, Sweden. Address: Scheelevägen 22, Lund, Sweden, 223 63
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service